A detailed history of Morgan Stanley transactions in Inari Medical, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,150,771 shares of NARI stock, worth $172 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,150,771
Previous 1,161,258 85.21%
Holding current value
$172 Million
Previous $47.9 Million 129.32%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$40.61 - $58.21 $40.2 Million - $57.6 Million
989,513 Added 85.21%
2,150,771 $110 Million
Q3 2024

Nov 14, 2024

BUY
$40.68 - $58.62 $1.65 Million - $2.38 Million
40,519 Added 3.62%
1,161,258 $47.9 Million
Q2 2024

Oct 17, 2024

SELL
$37.11 - $50.69 $16.8 Million - $23 Million
-452,935 Reduced 28.78%
1,120,739 $54 Million
Q2 2024

Aug 14, 2024

SELL
$37.11 - $50.69 $16.8 Million - $23 Million
-452,935 Reduced 28.78%
1,120,739 $54 Million
Q1 2024

Oct 17, 2024

BUY
$40.65 - $65.76 $18.4 Million - $29.8 Million
452,935 Added 40.41%
1,573,674 $75.5 Million
Q1 2024

Aug 16, 2024

BUY
$40.65 - $65.76 $32 Million - $51.7 Million
786,692 Added 99.96%
1,573,674 $75.5 Million
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $32 Million - $51.7 Million
786,692 Added 99.96%
1,573,674 $75.5 Million
Q4 2023

Aug 16, 2024

SELL
$48.3 - $68.06 $16.1 Million - $22.7 Million
-333,757 Reduced 29.78%
786,982 $51.1 Million
Q4 2023

Feb 13, 2024

SELL
$48.3 - $68.06 $5.67 Million - $7.99 Million
-117,467 Reduced 12.99%
786,982 $51.1 Million
Q3 2023

Nov 15, 2023

SELL
$54.2 - $71.67 $4.86 Million - $6.43 Million
-89,742 Reduced 9.03%
904,449 $59.2 Million
Q2 2023

Aug 14, 2023

SELL
$56.23 - $71.17 $7.2 Million - $9.11 Million
-128,048 Reduced 11.41%
994,191 $57.8 Million
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $8.09 Million - $10.3 Million
-151,391 Reduced 11.89%
1,122,239 $69.3 Million
Q4 2022

Feb 14, 2023

BUY
$61.23 - $83.62 $62.4 Million - $85.2 Million
1,019,378 Added 400.93%
1,273,630 $81 Million
Q3 2022

Nov 14, 2022

SELL
$65.58 - $84.69 $876,476 - $1.13 Million
-13,365 Reduced 4.99%
254,252 $18.5 Million
Q2 2022

Oct 27, 2022

BUY
$52.13 - $93.81 $4.19 Million - $7.53 Million
80,288 Added 42.86%
267,617 $18.2 Million
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $4.19 Million - $7.53 Million
80,288 Added 42.86%
267,617 $18.2 Million
Q1 2022

Oct 27, 2022

SELL
$64.92 - $99.47 $5.21 Million - $7.99 Million
-80,288 Reduced 30.0%
187,329 $17 Million
Q1 2022

May 13, 2022

BUY
$64.92 - $99.47 $4.47 Million - $6.84 Million
68,781 Added 58.02%
187,329 $17 Million
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $4.42 Million - $5.43 Million
-57,772 Reduced 32.77%
118,548 $10.8 Million
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $12.6 Million - $16.9 Million
176,320 New
176,320 $14.3 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.27B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.